Literature DB >> 3905047

The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.

A K Pedersen, G A FitzGerald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3905047     DOI： 10.1161/01.cir.72.6.1164

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration.

Authors:  T DiPerri; F L Pasini; C Frigerio; P Blardi; F Centini; G L Messa; A Ghezzi; L Volpi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  [Not Available].

Authors:  E Hackenthal
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

3.  5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.

Authors:  F De Clerck; W Loots; Y Somers; J Beetens; L Wouters; J Wynants; P A Janssen
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

Review 4.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 5.  A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?

Authors:  Ming-Han H Lee; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Pharmacokinetics and pharmacodynamics of L-703,014, a potent fibrinogen receptor antagonist, after intravenous and oral administration in the dog.

Authors:  J S Barrett; R J Gould; J D Ellis; M M Holahan; M T Stranieri; J J Lynch; G D Hartman; N Ihle; M Duggan; O A Moreno
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.